Ampio Pharmaceuticals
AMPE
£0.06260
Share price
0.06%
Change (1 day)
N/A
Change (1 year)
Categories
Operating Margin for Ampio Pharmaceuticals (AMPE)
Operating Margin as of July 2025 (TTM): -7,347.71%
According to Ampio Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -7,347.71%. At the end of 2013 the company had an Operating Margin of -49,056.06%.
Operating Margin history for Ampio Pharmaceuticals from 2012 to 2015
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2013 | -49,056.06% | 111.58% |
| 2012 | -23,185.25% | -76.21% |
| 2011 | -97,473.28% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Aerie Pharmaceuticals AERI | -10.86% | -99.85% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 18.78% | -100.26% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | -79.07% | -98.92% | 🇺🇸 USA |
 Rigel Pharmaceuticals RIGL | 10.24% | -100.14% | 🇺🇸 USA |
 Abbott Laboratories ABT | 17.36% | -100.24% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 35.38% | -100.48% | 🇺🇸 USA |
 Pfizer PFE | 12.60% | -100.17% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.